CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Amgen Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


Return On Equity (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Equity Change -22.63 % -1.59 % -2.73 % 0.29 % -
Y / Y Net Income Change -74.27 % -9.81 % -5.17 % 2.69 % -17.26 %
Net Income (TTM) in Millions 5,746 7,085 7,264 7,352 7,299
Return On Equity (TTM) 60.57 % 70.22 % 71.72 % 72.12 % 71.66 %
Total Ranking # 223 # 143 # 111 # 94 # 87
Equity (TTM) in Millions 8,247 9,334 9,409 10,959 10,659
Seq. Equity Change -11.65 % -0.8 % -14.14 % 2.81 % 12.38 %
Seq. Net Income Change -71.81 % 1.92 % -20.09 % 12.09 % -1.21 %


Roe Comment
Amgen Inc returned in II. Quarter 60.57 % on shareholder's equity, and it was higher than Amgen Inc average return on equity.

ROE decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 31 other companies have achieved higher return on equity. While Return on equity total ranking has deteriorated compare to previous quarter from 145 to 223.

What is ROE?
Return On Equity Company Ranking
Within: No.
Industry # 7
Sector # 32
Overall # 223

Return On Equity Statistics
High Average Low
75.1 %
25.93 %
6.61 %
(Mar 31 2020)   (Dec 31 2017)


Annual Return On Equity (Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
(Dec 31 2016)
2016
Total Equity in Millions 9,409 9,673 12,500 25,241 29,875
Y / Y Equity Change -2.73 % -22.62 % -50.48 % -15.51 % 6.38 %
Net Income in Millions 7,264 7,842 8,394 1,979 7,722
Y / Y Net Income Change -7.37 % -6.58 % 324.15 % -74.37 % 11.28 %
Return On Equity 77.2 % 81.07 % 67.15 % 7.84 % 25.85 %





Annual Roe Comment
In 2020 ROE decreased compare to previous year to 77.2 %, due to detoriation of net income.


Financial Statements
Amgen Inc 's Equity $ 8,247 Millions AMGN's Balance sheet
Amgen Inc 's Income $ 464 Millions Quarterly AMGN's Income Statement
AMGN's Income by Division See AMGN's Income by Division

More Return On Equity Ratios
Biotechnology & Drugs Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
Roe Trends for overall market
AMGN's Roe Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for AMGN's Competitors
Return On Equity for Amgen Inc 's Suppliers
Roe for AMGN's Customers

You may also want to know
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Statistics
AMGN's Annual Roe AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roi AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio



Companies with similar Return On Equity at Jun 30 2021, within Healthcare Sector ROE
Vyne Therapeutics Inc   138.73 %
Agios Pharmaceuticals Inc   129.96 %
Idexx Laboratories Inc  115.33 %
Molecular Templates Inc   107.63 %
Hanger inc   107.52 %
Tenet Healthcare Corp  100.88 %
Eli Lilly And Company  98.77 %
Ovid Therapeutics Inc   91.02 %
Retractable Technologies Inc  89.38 %
Moderna Inc   88.13 %
Vaso Corporation  80.89 %
Integrated Biopharma Inc  80.87 %
Alpha Pro Tech Ltd  79.65 %
Fulgent Genetics Inc   79.61 %
Uniqure N v   77.18 %
Integrity Applications Inc   71.81 %
Quidel Corporation  70.79 %
Davita Inc   70.43 %
Chemomab Therapeutics Ltd   69.93 %
Intersect Ent Inc   69.23 %
Semler Scientific inc   68.78 %
Manhattan Scientifics Inc   67.38 %
Co diagnostics Inc   65.33 %
Amgen Inc   60.57 %
Innoviva inc   60.40 %
Biomx Inc   59.71 %
Hologic Inc  59.58 %
The Cooper Companies Inc   59.14 %
Antares Pharma Inc   58.38 %
Collegium Pharmaceutical inc   57.97 %



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DISA's Profile

Stock Price

DISA's Financials

Business Description

Fundamentals

Charts & Quotes

DISA's News

Suppliers

DISA's Competitors

Customers & Markets

Economic Indicators

DISA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071